ROSEN, NATIONAL TRIAL COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK
NEW YORK CITY, NY / ACCESS Newswire / March 16, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds ...
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK
To join the GSK class action, go to https://rosenlegal.com/submit-form/?case_id=34609 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class ...
pharmaphorum23h
Next stage in GSK’s Zantac defense gets underway today
A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients. The three-day hearing ...
Taiwan News21h
Nasal Polyposis Treatment Market Valued at USD 4.6 Billion in 2023, Expected to Grow at 6.3% CAGR Through 2032
Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8527 ...
Taiwan News21h
Myocarditis Treatment Market Valued at USD 1.5 Billion in 2023, Projected to Grow at 5.6% CAGR Through 2032
Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8528 ...